Pages that link to "Q73705668"

The following pages link to DBA/1 mice expressing the human TNF-alpha transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition (Q73705668):

Displaying 43 items.

• A model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKL (Q24799036) (← links)
• Anti-TNF-alpha antibody allows healing of joint damage in polyarthritic transgenic mice (Q24801075) (← links)
• A follow-up to "Anti-cytokine therapy in chronic destructive arthritis" by Wim B van den Berg (Q24805534) (← links)
• A new model for rheumatoid arthritis? (Q24806715) (← links)
• Macrophages in rheumatoid arthritis (Q24806949) (← links)
• Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity (Q24816615) (← links)
• An extensive phenotypic characterization of the hTNFalpha transgenic mice (Q33309488) (← links)
• Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice (Q33504871) (← links)
• U-Bang-Haequi Tang: A Herbal Prescription that Prevents Acute Inflammation through Inhibition of NF-κB-Mediated Inducible Nitric Oxide Synthase (Q33737304) (← links)
• PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases (Q33782360) (← links)
• Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha (Q34071308) (← links)
• Humanized mice as a model for rheumatoid arthritis (Q34731162) (← links)
• The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis (Q35208754) (← links)
• IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints (Q35552036) (← links)
• Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases (Q35630027) (← links)
• Systemic inflammation and neurodegeneration in a mouse model of multiple sulfatase deficiency (Q35663888) (← links)
• TNF-induced structural joint damage is mediated by IL-1. (Q35880188) (← links)
• CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis. (Q35919881) (← links)
• Macrophage- and neutrophil-dominant arthritis in human IL-1 alpha transgenic mice (Q36166760) (← links)
• Analysing the effect of novel therapies on cytokine expression in experimental arthritis (Q36271120) (← links)
• Inhibition of IL-1, IL-6, and TNF-alpha in immune-mediated inflammatory diseases (Q36494210) (← links)
• The complex role of Fcgamma receptors in the pathology of arthritis (Q36624577) (← links)
• Establishment and evaluation of a transgenic mouse model of arthritis induced by overexpressing human tumor necrosis factor alpha (Q36961325) (← links)
• Cells of the synovium in rheumatoid arthritis. Chondrocytes (Q37000837) (← links)
• Target effector role of vascular endothelium in the inflammatory response: insights from the clinical trial of anti-TNF alpha antibody in rheumatoid arthritis (Q37229283) (← links)
• Harnessing the natural inhibitory domain to control TNFα Converting Enzyme (TACE) activity in vivo (Q37508401) (← links)
• Noncoding RNAs and LRRFIP1 regulate TNF expression (Q37662735) (← links)
• A 129-kb deletion on chromosome 12 confers substantial protection against rheumatoid arthritis, implicating the gene SLC2A3. (Q37715658) (← links)
• Do RANKL inhibitors (denosumab) affect inflammation and immunity? (Q37767159) (← links)
• Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis: an evidence-based review (Q37804381) (← links)
• The p38 MAPK Pathway in Rheumatoid Arthritis: A Sideways Look (Q38048776) (← links)
• A trimeric structural fusion of an antagonistic tumor necrosis factor-α mutant enhances molecular stability and enables facile modification (Q38714957) (← links)
• The type I interferon signaling pathway is a target for glucocorticoid inhibition. (Q39672500) (← links)
• Role of glucocorticoid-induced leucine zipper (GILZ) in inflammatory bone loss. (Q41236945) (← links)
• Anti-inflammatory effects of systemic anti-tumour necrosis factor alpha treatment in human/murine SCID arthritis. (Q42045602) (← links)
• DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes (Q42117977) (← links)
• Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF-α)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13 (Q45885757) (← links)
• The roles of interleukin-18 in collagen-induced arthritis in the BB rat. (Q47594386) (← links)
• The Role of Flavonoids in Inhibiting Th17 Responses in Inflammatory Arthritis. (Q52716891) (← links)
• Humanized Mouse Models of Rheumatoid Arthritis for Studies on Immunopathogenesis and Preclinical Testing of Cell-Based Therapies (Q64228779) (← links)
• An anti-inflammatory role for interleukin-11 in established murine collagen-induced arthritis (Q77394194) (← links)
• Evaluation of inflammatory change and bone erosion using a murine type II collagen-induced arthritis model (Q82397636) (← links)
• Cholecystokinin octapeptide exerts its therapeutic effects on collagen-induced arthritis by suppressing both inflammatory and Th17 responses (Q84021987) (← links)